Yan Wang

Dr. Yan Wang


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2022 in Canadian Respiratory Journal
Verified
Journal Article
Open access
PDF file
YQYuanjie Qiu
Yuanjie Qiu
YWYan Wang
Yan Wang
NSNirui Shen
Nirui Shen
QWQingting Wang
Qingting Wang
LCLimin Chai
Limin Chai
MLManxiang Li
Manxiang Li
Background. Chronic obstructive pulmonary disease (COPD) is a common chronic disease. Progression is further exacerbated by the coexistence of cardiovascular disease (CVD). We aim to construct a diagnostic nomogram for predicting the risk of coexisting CVD and a prognostic nomogram for predicting long-term survival in COPD. Methods. The 540 eligible participants selected from the NHANES 20052010 were included in this study. Logistic regression analysis was used to construct a diagnostic nomogram for the diagnosis of coexisting CVD in COPD. Cox regression analyses were used to construct a prognostic nomogram for COPD. A risk stratification system was developed based on the total score generated from the prognostic nomogram. We used C-index and ROC curves to evaluate the discriminant ability of the newly built nomograms. The models were also validated utilizing calibration curves. Survival curves were made using the KaplanMeier method and compared by the Log-rank test. Results. Logistic regression analysis showed that gender, age, neutrophil, RDW, LDH, and HbA1c were independent predictors of coexisting CVD and were included in the diagnostic model. Cox regression analysis indicated that CVD, gender, age, BMI, RDW, albumin, LDH, creatinine, and NLR were independent predictors of COPD prognosis and were incorporated into the prognostic model. The C-index and ROC curves revealed the good discrimination abilities of the models. And the calibration curves implied that the predicted values by the nomograms were in good agreement with the actual observed values. In addition, we found that coexisting with CVD had a worse prognosis compared to those without CVD, and the prognosis of the low-risk group was better than that of the high-risk group in COPD. Conclusions. The nomograms we developed can help clinicians and patients to identify COPD coexisting CVD early and predict the 5-year and 10-year survival rates of COPD patients, which has some clinical practical values.


1 March 2020 in Annals of Palliative Medicine
Verified
Journal Article
Open access
PDF file
DHDong Huang
Dong Huang
YWYan Wang
Yan Wang
YWYu Wang
Yu Wang
ZLZong-An Liang
Zong-An Liang
Background: Tuberculosis and diabetes mellitus are both important global health problems now. Previous studies have drawn different conclusions about the impact of diabetes on drug resistance in patients with newly diagnosed tuberculosis. Methods: We conducted a systematic search in four databases: PubMed, EMBSE, Cochrane Library, and Web of Science. The relative risk (RR) was applied to assess the association of diabetes with drug resistance and the STATA version 12.0 was used for data synthesis. Results: A total of 13 studies involving 33,747 patients were included in our study. The pooled results revealed that presence of diabetes was significantly associated with isoniazid resistance (RR =1.22, 95% CI: 1.04–1.43) in patients with newly diagnosed tuberculosis. However, no significant impact of diabetes on rifampicin resistance (RR =0.67, 95% CI: 0.41–1.11) or multi-drug resistance (MDR) (RR =1.28, 95% CI: 0.93–1.75) was observed. The results of subgroup analysis were similar to the pooled results. No significant publication bias for the results of MDR was found. Conclusions: In patients with newly diagnosed tuberculosis, diabetes is associated with isoniazid resistance. However, there is no significant impact of diabetes on the rifampicin resistance or MDR. However, these findings still need to be verified in the future.

21 September 2023 in Photochemistry and Photobiology
Verified
Journal Article
Closed access
YGYan Guo
Yan Guo
YKYue Kong
Yue Kong
JSJuan Sun
Juan Sun
YJYang Jiao
Yang Jiao
YHYan Hong
Yan Hong
YWYan Wang
Yan Wang

7 November 2015 in Expert Opinion on Pharmacotherapy
Verified
Journal Article
Closed access
LLLi-Peng Liu
Li-Peng Liu
YWYan Wang
Yan Wang
RSRui Si
Rui Si
MYMing Yuan
Ming Yuan
KCKang Cheng
Kang Cheng
WGWen-Yi Guo
Wen-Yi Guo
Objectives: Controversy has been prompted based on drug interaction between proton pump inhibitors (PPIs) and aspirin/clopidogrel leading to weakened effects. However, whether such interaction was ...

1 May 2020 in Medicine
Verified
Journal Article
Open access
YWYan Wang
Yan Wang
SLShan Lin
Shan Lin
CLChenxi Li
Chenxi Li
YSYingqing Shi
Yingqing Shi
WGWei Guan
Wei Guan
Introduction: Sleep apnea–hypopnea syndrome (SAHS) is a multifactorial disease characterized by recurrent hypopnea or respiratory interruption during sleep, which causes intermittent hypoxemia, hypercapnia, and sleep structure disturbances. An association between ankylosing spondylitis (AS) and the type of SAHS has rarely been reported in the literature. Here, we present a case of SAHS in a patient with AS and discuss the possible mechanism underlying the type of SAHS. Patient concerns: A 46-year-old man presented with a 15-year history of AS. He had been receiving sulfasalazine for symptomatic relief and had never been on immunosuppressive therapy. Diagnosis: The patient was diagnosed with SAHS in addition to AS. Interventions: We instituted treatment with methylprednisolone (5 mg, oral, daily), leflumomide (20 mg, oral, daily), bicyclol tablets (25 mg, oral, 3 times a day), and ursodeoxycholic acid tablets (10 mg/kg, oral, daily). The patient received etanercept (50 mg, sc, once a week) as his condition deteriorated. In addition, for management of SAHS symptoms, the patient received nasal continuous positive airway pressure (CPAP) during sleep. Outcomes: Six months after commencement of the treatment, the clinical manifestations of SAHS and AS had significantly improved. Conclusions: We hypothesize that patients with AS are prone to sleep apnea due to airway compression, central depression of respiration, abnormal inflammatory responses. Hence, careful assessment toward potential SAHS symptoms should be considered especially in patients with AS.